Bioage Labs Inc (BIOA)

概要ニュース株価時系列ディスカッション予測

Relative Volume:

ネットキャッシュフロー:

Bioage Labs Inc Stock (BIOA) Company Profile

Bioage Labs Inc

Healthcare (1155)

510-806-1445

1445A SOUTH 50TH STREET, RICHMOND

BIOA's Discussions on Twitter

BIOA を他の銘柄と比較する

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
BIOA Bioage Labs Inc	4.375	144.12M	0	0	0	0.00
ZTS Zoetis Inc	153.80	65.50B	9.26B	2.49B	2.30B	5.47
TAK Takeda Pharmaceutical Co Adr	15.16	46.99B	30.25B	1.37B	5.08B	0.4257
HLN Haleon Plc Adr	10.23	45.96B	14.35B	1.85B	0	0.4023
TEVA Teva Pharmaceutical Industries Ltd Adr	15.04	17.04B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	297.31	12.77B	2.76B	1.11B	898.10M	22.77

Bioage Labs Inc Stock (BIOA) Upgrades & Downgrades

日付	アクション	アナリスト	評価の変更
2025-02-28	開始されました	William Blair	Mkt Perform
2024-12-10	ダウングレード	Morgan Stanley	Overweight → Underweight
2024-12-09	ダウングレード	Citigroup	Buy → Neutral
2024-12-09	ダウングレード	Jefferies	Buy → Hold
2024-10-21	開始されました	Citigroup	Buy
2024-10-21	開始されました	Jefferies	Buy
2024-10-21	開始されました	Morgan Stanley	Overweight

Bioage Labs Inc (BIOA) 最新ニュース

Bioage Labs Inc (BIOA) 財務データ

Bioage Labs Inc (BIOA) の財務データはありません。詳細については、他の銘柄を確認してください。

Bioage Labs Inc (BIOA)

Bioage Labs Inc Stock (BIOA) Company Profile

BIOA を他の銘柄と比較する

Bioage Labs Inc Stock (BIOA) Upgrades & Downgrades

Bioage Labs Inc (BIOA) 最新ニュース

Press Release Distribution & PR Platform - ACCESS Newswire

Investors who hold shares of BioAge Labs, Inc. (NASDAQ: BIOA) - openPR.com

Notice to Long-Term Shareholders of BioAge Labs, Inc. - GlobeNewswire

Notice to Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); Driven Bands Holdings - Bluefield Daily Telegraph

BioAge Labs, Inc. (BIOA): A Bull Case Theory - Insider Monkey

Grabar Law Office Investigates Claims on Behalf of - GlobeNewswire

Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); NAPCO Security Technologies, Inc. (NASDAQ: NSSC); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Virtu Financial Inc. (NASDAQ: VI - TradingView

BIOA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that BioAge Labs, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

BioAge Labs (BIOA) Shares Plummet After Discontinuing Trial Just 2 Months After IPOHagens Berman - ACCESS Newswire

Several Insiders Invested In BioAge Labs Flagging Positive News - Yahoo Finance

Cautious Outlook on BioAge Labs Amid Promising Developments and High Risk - TipRanks

BioAge Labs, Inc.: Sell Rating Due to Discontinued Program and Uncertain Prospects - TipRanks

William Blair Sticks to Its Hold Rating for BioAge Labs, Inc. (BIOA) - The Globe and Mail

BioAge Labs Inc. (BIOA) reports earnings - Quartz

BioAge Labs, Inc. Advances NLRP3 Inhibitor BGE-102 and Forms Strategic Collaborations with Novartis and Lilly for Metabolic Diseases - Nasdaq

BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the - Bluefield Daily Telegraph

BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024 - TradingView

BioAge Labs Lands Massive $550M Novartis Deal Despite Clinical Setback in 2024 Results - Stock Titan

Final Deadline for the BioAge Labs, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsBIOA - The Malaysian Reserve

BIOA Deadline Today: BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit - PR Newswire

BIOA DEADLINE TODAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors - Bluefield Daily Telegraph

BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire

Bioage Labs principal accounting officer Barton Shane buys $47,376 in common stock By Investing.com - Investing.com South Africa

Bioage Labs principal accounting officer Barton Shane buys $47,376 in common stock - Investing.com

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs - Markets Insider

Lost Money on BioAge Labs, Inc. (BIOA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - GlobeNewswire

Lost Money on BioAge Labs, Inc. (BIOA)? Join Class Action Suit Seeking Recovery – Contact Levi ... - Bluefield Daily Telegraph

2025-03-10 | Shareholders that Lost Money on BioAge Labs, Inc. (BIOA) Should Contact Levi & Korsinsky About Pending Class ActionBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing

DEADLINE ALERT for REGN and BIOA: The Law Offices of Frank - GlobeNewswire

March 10, 2025 Filing Deadline in Securities Class ActionContact Kessler Topaz Meltzer & - FinancialContent

BIOA FINAL DEADLINE: BioAge Labs Investors are Encouraged - GlobeNewswire

Lost Money on BioAge Labs, Inc.(BIOA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - ACCESS Newswire

BIOA Final Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm - themalaysianreserve.com

Investors in BioAge Labs, Inc. Should Contact The Gross Law Firm Before March 10, 2025 to Discuss Your RightsBIOA - GuruFocus.com

BioAge Labs, Inc. Class Action: The Gross Law Firm Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025BIOA - PR Newswire

2025-03-09 | Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 10, 2025 in BioAge Labs, Inc. LawsuitBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing

Class Action Filed Against BioAge Labs, Inc. (BIOA)March 10, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire

BioAge Labs, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before March 10, 2025 to Discuss Your RightsBIOA - ACCESS Newswire

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs - StreetInsider

BIOA Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. (BIOA) Investors of Filing Deadline in Class Action Lawsuit | StreetInsider.com - Financial Content

BIOA LEGAL NEWS: A Class Action was filed on behalf of BioAge Labs Investors - GlobeNewswire Inc.

BioAge Labs (BIOA) Abandons Obesity Drug Amid Shareholder Lawsuit – Hagens Berman - GlobeNewswire

Faruqi & Faruqi Reminds BioAge Investors of the Pending Class Act - The National Law Review

BIOA Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP - GlobeNewswire

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge ... - Bluefield Daily Telegraph

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge Labs, Inc. (BIOA) Shareholders - GlobeNewswire

BIOA DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors ... - The Bakersfield Californian

Deadline Soon: BioAge Labs, Inc. (BIOA) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - Business Wire

BIOA Deadline: Rosen Law Firm Urges BioAge Labs, Inc. (NASDAQ: BIOA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - Joplin Globe

Cautious Outlook on BioAge Labs, Inc. Amid Program Discontinuation and Development Risks - TipRanks

Faruqi & Faruqi Reminds BioAge Investors of the Pending - GlobeNewswire

Bioage Labs Inc (BIOA) 財務データ

収益

当期純利益

現金流量

EPS

BIOAに似た銘柄